PDS Biotechnology (PDSB) Return on Capital Employed [ROCE] (2015 - 2026)
PDS Biotechnology's Return on Capital Employed [ROCE] was -397.83% in Q2 2026, down 291.48 percentage points from -106.35% a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at PDS Biotechnology came in at -110.90%, down 7.97 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for four consecutive years, with a five-year change of -34.17 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -102.93% in FY2024 (-24.05 pp), -78.88% in FY2023 (-11.97 pp), -66.91% in FY2022 (-19.57 pp) and -47.34% in FY2021 (+29.40 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2015.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 42.19 percentage points); the worst was Q2 2026 (a drop of 291.48 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | PDS Biotechnology | 57.60 Mn | -22.61 Mn | - | -638.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -638.71% |
| Mar 31, 2026 | -166.13% |
| Dec 31, 2025 | -136.46% |
| Sep 30, 2025 | -132.84% |
| Jun 30, 2025 | -106.35% |
| Mar 31, 2025 | -126.50% |
| Dec 31, 2024 | -114.15% |
| Sep 30, 2024 | -103.24% |
| Jun 30, 2024 | -80.91% |
| Mar 31, 2024 | -88.98% |
| Dec 31, 2023 | -96.39% |
| Sep 30, 2023 | -100.28% |
| Jun 30, 2023 | -82.85% |
| Mar 31, 2023 | -62.12% |
| Dec 31, 2022 | -63.02% |
| Sep 30, 2022 | -48.14% |
| Jun 30, 2022 | -53.43% |
| Mar 31, 2022 | -45.46% |
| Dec 31, 2021 | -32.62% |
| Sep 30, 2021 | -26.97% |
API Access
PDS Biotechnology Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();